University Children's Hospital Zurich, Psychosomatic and Psychiatry
Zurich, CH-8032, Switzerland
NCT Number: NCT00296907
The purpose of the study is to evaluate the effectiveness of a two-session brief psychological intervention in siblings of pediatric cancer patients with regard to behavior problems and depression.
Looking for future studies?
Notify MeWithin a randomized controlled design the effects of a brief two-session psychological intervention (child, parents) shall be studied in 30 siblings of newly diagnosed pediatric cancer patients. After a baseline assessment 3-4 weeks after diagnosis participants are randomly assigned to an intervention or waiting list group. Both are re-assessed at 3 and 6 months by means of standardized questionnaires assessing psychological adaptation and behavior. The intervention is provided to the waiting list group after the 6-month assessment.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
brother or sister with newly diagnosed cancer treated at the University Children's Hospital command of the German language normal developmental level
Exclusion criteria
Psychoeducation, provision of medical knowledge, coping skills training
Time frame: baseline, 3 and 6 months post intervention
Time frame: baseline, 3 and 6 months post intervention
Time frame: baseline, 3 and 6 months post intervention
Time frame: Baseline, 3 and 6 months post intervention
Time frame: baseline, 3 and 6 months post intervention
Time frame: baseline, 3 and 6 months post intervention
Time frame: baseline, 3 and 6 months post intervention
University Children's Hospital, Zurich
Other
Psychological Interventions in Siblings of Children With Cancer: a Randomized Controlled Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04598646
Behavior, Cancer
Toronto, Ontario, Canada
View Trial DetailsNCT03847753
Acquired Immunodeficiency Syndrome, Allergy
View Trial DetailsNCT03548077
Behavior, Cancer
Kelowna, British Columbia, Canada
View Trial DetailsNCT00674804
Behavior, Cancer
Bethesda, Maryland, United States
View Trial Details